Apeiron Capital Ltd holds a concentrated book of 14 stocks worth $155.7M as of Q2 2026 (disclosed Aug 6, 2026, a ~37-day 13F lag). This quarter they opened Direxion Daily Mu Bull 2X Et and trimmed On Holding AG-Class A. Their largest long position is Direxion Daily Mu Bull 2X Et at 23% of the equity book. Cloning the disclosed picks since 2024 would be -6% (-3.3%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1843111/holdings"
Use Arkolith to show APEIRON CAPITAL Ltd's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 10.7 points over this window.
Growth of $10,000 cloning Apeiron Capital Ltd's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~37 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
77% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Apeiron Capital Ltd
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| MORGAN STANLEY | 41 / 14 | $177.4B |
| GOLDMAN SACHS GROUP INC | 41 / 14 | $92.3B |
| UBS Group AG | 41 / 14 | $46.4B |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 41 / 14 | $9.6B |
| OSAIC HOLDINGS, INC. | 41 / 14 | $3.6B |
| CITIGROUP INC | 40 / 14 | $21.8B |
| BlackRock, Inc. | 39 / 14 | $802.9B |
| JPMORGAN CHASE & CO | 39 / 14 | $173.7B |
Ranked by how many of Apeiron Capital Ltd's top 14 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Direxion Daily Mu Bull 2X Et DLY MU BULL 2X | $35.7M | 34.0K | 22.9% | ▲New New position | |
| 2 | On Holding AG-Class A NAMEN AKT A | $28.2M | 795.9K | 18.1% | ▼−20% Reduced · −200K sh | |
| 3 | Abivax Sa-ADR SPONSORED ADS | $17.4M | 130.6K | 11.2% | ▲New New position | |
| 4 | Qfin Holdings Inc-ADR AMERICAN DEP | $15.4M | 976.2K | 9.9% | ▼−5.4% Reduced · −56K sh | |
| 5 | Summit Therapeutics Inc COM | $14.0M | 961.9K | 9.0% | ▼−27% Reduced · −347K sh | |
| 6 | Taiwan Semiconductor-SP ADR SPONSORED ADS | $8.5M | 17.9K | 5.5% | ▲+103% Added · +9K sh | |
| 7 | Western Digital Corp COM | $8.3M | 13.0K | 5.3% | ▲New New position | |
| 8 | Nektar Therapeutics COM NEW | $7.4M | 106.4K | 4.8% | ▲New New position | |
| 9 | Nokia Corp-Spon ADR SPONSORED ADR | $5.0M | 378.5K | 3.2% | ▲New New position | |
| 10 | Seagate Technology Holdings ORD SHS | $4.8M | 5.0K | 3.1% | ▲New New position | |
| 11 | Sandisk Corp COM | $3.6M | 1.6K | 2.3% | ▲New New position | |
| 12 | Lumentum Holdings Inc COM | $3.0M | 3.5K | 1.9% | ▲New New position | |
| 13 | Trip.com Group Ltd-ADR ADS | $2.8M | 70.0K | 1.8% | —Held | |
| 14 | Poet Technologies Inc COM NEW | $1.5M | 142.0K | 0.9% | ▲New New position |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 | 14 | $155.7M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 22, 2026 | 13 | $106.9M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 2, 2026 | 5 | $86.5M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 28, 2025 | 8 | $210.4M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 25, 2025 | 5 | $105.9M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 23, 2025 | 11 | $217.6M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 7, 2025 | 13 | $268.3M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 1, 2024 | 10 | $280.3M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.